ABPN Neurocritical Care study plan

Map each major cerebrovascular entity (ischemic stroke, ICH, SAH, CVST, arterial dissection) to its acute ICU management priorities

Explain the physiologic rationale for blood pressure targets in ischemic stroke, ICH, and SAH and state the numeric targets

Describe indications, contraindications, and monitoring requirements for IV thrombolysis and endovascular thrombectomy in the ICU setting

Outline ICU management of aneurysmal SAH including vasospasm surveillance, nimodipine, and hydrocephalus management

Integrate post-thrombectomy and post-thrombolysis ICU monitoring with hemodynamic and airway management principles

Apply cerebral autoregulation and cerebral perfusion pressure concepts to set MAP goals in acute brain injury

Select fluid resuscitation strategy and distinguish isotonic crystalloid from hypotonic and colloid options in neurocritically ill patients

Identify cardiac complications of acute stroke (neurogenic stunned myocardium, arrhythmia) and adjust management accordingly

Classify traumatic brain injury by severity and morphologic subtype and match each to initial ICU management

Apply the Monro-Kellie doctrine to explain tiered ICP management strategies from osmotherapy through decompressive surgery

Interpret ICP and CPP waveforms and state thresholds that trigger escalation

Distinguish neurogenic from spinal shock in acute spinal cord injury and outline hemodynamic and respiratory support for each

Recognize and manage paroxysmal sympathetic hyperactivity and other autonomic complications of severe brain injury

Differentiate convulsive, nonconvulsive, and refractory status epilepticus and state time-based treatment escalation

Sequence benzodiazepine dosing followed by second-line antiseizure medication and anesthetic infusion for refractory status

Identify EEG patterns of nonconvulsive status and explain when continuous EEG monitoring is indicated in the unresponsive ICU patient

List adverse effects and monitoring requirements of continuous anesthetic infusions for refractory status

Outline recognition and ICU management of Guillain-Barre syndrome and myasthenic crisis including respiratory monitoring and indications for intubation

Explain the mechanism, dosing, and monitoring of plasma exchange and IVIG in neuromuscular ICU disease

Identify neuroinfectious emergencies (bacterial meningitis, HSV encephalitis, cerebral malaria considerations) and state empiric therapy principles

Predict toxicologic causes of altered mental status and seizures and describe antidotal or enhanced-elimination strategies

Match sedatives, analgesics, and antiseizure drugs to their key pharmacokinetic pitfalls in critically ill patients

Describe postoperative ICU management after craniotomy, including hematoma surveillance and seizure prophylaxis decisions

Outline perioperative and ICU care for the neurosurgical patient on anticoagulation or antiplatelet therapy

Explain management of hydrocephalus and external ventricular drain care including infection prevention and weaning assessment

Identify postoperative complications of pituitary and skull base surgery including endocrine and CSF leak issues

Manage systemic complications of neurocritical illness: ventilator-associated pneumonia, VTE prophylaxis, dysphagia, and nutrition

Apply brain-lung and brain-kidney interactions to ventilator and renal replacement decisions

Interpret noncontrast CT, CT angiography, MRI, and transcranial Doppler findings in acute neurocritical scenarios

Explain multimodality neuromonitoring (ICP, PbtO2, cerebral microdialysis, NIRS) and how each signal changes management

State the clinical prerequisites and apnea testing procedure for brain death determination

Apply a structured prognostication framework after cardiac arrest and severe TBI that avoids premature withdrawal decisions

Explain surrogate decision-making, substituted judgment, and conflict resolution in the ICU

Describe organ donation pathways after brain death and the clinician's communication responsibilities

Integrate all domains through timed mixed-topic review and identify remaining weak areas for continued study